Table of Contents Global Blood Cancer Therapeutics Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Blood Cancer Therapeutics Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Blood Cancer Therapeutics Segment by Type 1.2.1 Chronic Myeloid Leukemia (CML) 1.2.2 Acute Lymphocytic Leukemia (ALL) 1.2.3 Chronic Lymphocytic Leukemia (CLL) 1.2.4 Acute Myeloid Leukemia (AML) 1.3 Market Analysis by Application 1.3.1 Cancer Research Centers 1.3.2 Cancer Hospital 1.3.3 Surgical Centers 1.3.4 Clinics 1.4 Overview of Global Blood Cancer Therapeutics Market 1.4.1 Global Blood Cancer Therapeutics Revenue (2015-2025) 1.4.2 Global Blood Cancer Therapeutics Production and Capacity (2015-2025) 1.4.3 North America Blood Cancer Therapeutics Status and Prospect (2015-2025) 1.4.4 Europe Blood Cancer Therapeutics Status and Prospect (2015-2025) 1.4.5 Japan Blood Cancer Therapeutics Status and Prospect (2014-2025) 1.4.6 China Blood Cancer Therapeutics Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Blood Cancer Therapeutics Industry Impact 1.6.1 How the Covid-19 is Affecting the Blood Cancer Therapeutics Industry 1.6.2 Blood Cancer Therapeutics Business Impact Assessment - Covid-19 1.6.3 Market Trends and Blood Cancer Therapeutics Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Blood Cancer Therapeutics Market Competition by Manufacturer 2.1 Global Blood Cancer Therapeutics Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Blood Cancer Therapeutics Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Blood Cancer Therapeutics Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Blood Cancer Therapeutics Manufacturer Market Share 2.5 Top 10 Blood Cancer Therapeutics Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Blood Cancer Therapeutics Market 2.7 Key Manufacturers Blood Cancer Therapeutics Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Blood Cancer Therapeutics Industry Key Manufacturers 3.1 AbbVie 3.1.1 Company Details 3.1.2 Product Information 3.1.3 AbbVie Blood Cancer Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 AbbVie News 3.2 AstraZeneca 3.2.1 Company Details 3.2.2 Product Information 3.2.3 AstraZeneca Blood Cancer Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 AstraZeneca News 3.3 Bristol-Myers Squibb 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Bristol-Myers Squibb Blood Cancer Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Bristol-Myers Squibb News 3.4 GlaxoSmithKline 3.4.1 Company Details 3.4.2 Product Information 3.4.3 GlaxoSmithKline Blood Cancer Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 GlaxoSmithKline News 3.5 Roche 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Roche Blood Cancer Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Roche News 3.6 Novartis 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Novartis Blood Cancer Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Novartis News 3.7 Boehringer Ingelheim 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Boehringer Ingelheim Blood Cancer Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Boehringer Ingelheim News 3.8 Pfizer 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Pfizer Blood Cancer Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Pfizer News 3.9 Sanofi 3.9.1 Company Details 3.9.2 Product Information 3.9.3 Sanofi Blood Cancer Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.9.4 Main Business Overview 3.9.5 Sanofi News 4 Global Blood Cancer Therapeutics Market Size Categorized by Regions (2015-2020) 4.1 Global Blood Cancer Therapeutics Sales Market Share by Region 4.2 Global Blood Cancer Therapeutics Revenue Market Share by Region (2015-2019) 4.3 Global Blood Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Blood Cancer Therapeutics Market Size Detail 4.4.1 North America Blood Cancer Therapeutics Sales Growth Rate (2015-2020) 4.4.2 North America Blood Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Blood Cancer Therapeutics Market Size Detail 4.5.1 Europe Blood Cancer Therapeutics Sales Growth Rate (2015-2020) 4.5.2 Europe Blood Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Blood Cancer Therapeutics Market Size Detail 4.6.1 Japan Blood Cancer Therapeutics Sales Growth Rate (2015-2020) 4.6.2 Japan Blood Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Blood Cancer Therapeutics Market Size Detail 4.7.1 China Blood Cancer Therapeutics Sales Growth Rate (2015-2020) 4.7.2 China Blood Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Blood Cancer Therapeutics Market Segment by Type 5.1 Global Blood Cancer Therapeutics Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Blood Cancer Therapeutics Sales and Market Share by Type (2015-2020) 5.1.2 Global Blood Cancer Therapeutics Revenue and Market Share by Type (2015-2020) 5.2 Chronic Myeloid Leukemia (CML) Sales Growth Rate and Price 5.2.1 Global Chronic Myeloid Leukemia (CML) Sales Growth Rate (2015-2020) 5.2.2 Global Chronic Myeloid Leukemia (CML) Price (2015-2020) 5.3 Acute Lymphocytic Leukemia (ALL) Sales Growth Rate and Price 5.3.1 Global Acute Lymphocytic Leukemia (ALL) Sales Growth Rate (2015-2020) 5.3.2 Global Acute Lymphocytic Leukemia (ALL) Price (2015-2020) 5.4 Chronic Lymphocytic Leukemia (CLL) Sales Growth Rate and Price 5.4.1 Global Chronic Lymphocytic Leukemia (CLL) Sales Growth Rate (2015-2020) 5.4.2 Global Chronic Lymphocytic Leukemia (CLL) Price (2015-2020) 5.5 Acute Myeloid Leukemia (AML) Sales Growth Rate and Price 5.5.1 Global Acute Myeloid Leukemia (AML) Sales Growth Rate (2015-2020) 5.5.2 Global Acute Myeloid Leukemia (AML) Price (2015-2020) 6 Global Blood Cancer Therapeutics Market Segment by Application 6.1 Global Blood Cancer Therapeutics Sales Market Share by Application (2015-2020) 6.2 Cancer Research Centers Sales Growth Rate (2015-2020) 6.3 Cancer Hospital Sales Growth Rate (2015-2020) 6.4 Surgical Centers Sales Growth Rate (2015-2020) 6.5 Clinics Sales Growth Rate (2015-2020) 7 Blood Cancer Therapeutics Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Blood Cancer Therapeutics Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Blood Cancer Therapeutics Market Forecast 8.1 Global Blood Cancer Therapeutics Sales, Revenue Forecast 8.1.1 Global Blood Cancer Therapeutics Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Blood Cancer Therapeutics Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Blood Cancer Therapeutics Price and Trend Forecast (2020-2025) 8.2 Global Blood Cancer Therapeutics Sales Forecast by Region (2020-2025) 8.2.1 North America Blood Cancer Therapeutics Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Blood Cancer Therapeutics Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Blood Cancer Therapeutics Production, Revenue Forecast (2020-2025) 8.2.4 China Blood Cancer Therapeutics Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Blood Cancer Therapeutics Picture Table Global Blood Cancer Therapeutics Sales by Type Figure Global Sales Market Share of Blood Cancer Therapeutics by Product Type in 2019 Table Breakdown of Blood Cancer Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) Figure Blood Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Chronic Myeloid Leukemia (CML) Picture Figure Acute Lymphocytic Leukemia (ALL) Picture Figure Chronic Lymphocytic Leukemia (CLL) Picture Figure Acute Myeloid Leukemia (AML) Picture Table Global Blood Cancer Therapeutics Sales by Application Figure Global Blood Cancer Therapeutics Sales Market Share by Application in 2019 Figure Cancer Research Centers Picture Figure Cancer Hospital Picture Figure Surgical Centers Picture Figure Clinics Picture Table Blood Cancer Therapeutics Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Blood Cancer Therapeutics Revenue (Million US$) (2015-2025) Figure Global Blood Cancer Therapeutics Production (K Units) (2015-2025) Figure North America Blood Cancer Therapeutics Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Blood Cancer Therapeutics Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Blood Cancer Therapeutics Revenue (Million US$) Growth Rate (2014-2025) Figure China Blood Cancer Therapeutics Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Blood Cancer Therapeutics Sales by Manufacturer (2018-2020) Figure Global Blood Cancer Therapeutics Sales Market Share by Manufacturer in 2019 Table Global Blood Cancer Therapeutics Revenue by Manufacturer (2018-2020) Figure Global Blood Cancer Therapeutics Revenue Market Share by Manufacturer in 2019 Table Global Blood Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Blood Cancer Therapeutics Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Blood Cancer Therapeutics Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Blood Cancer Therapeutics Market Table Key Manufacturers Blood Cancer Therapeutics Product Type Table Mergers & Acquisitions Planning Table AbbVie Company Profile Figure Blood Cancer Therapeutics Product Picture and Specifications of AbbVie Table Blood Cancer Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure AbbVie Blood Cancer Therapeutics Market Share (2018-2020) Table AbbVie Main Business Table AbbVie Recent Development Table AstraZeneca Company Profile Figure Blood Cancer Therapeutics Product Picture and Specifications of AstraZeneca Table Blood Cancer Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure AstraZeneca Blood Cancer Therapeutics Market Share (2018-2020) Table AstraZeneca Main Business Table AstraZeneca Recent Development Table Bristol-Myers Squibb Company Profile Figure Blood Cancer Therapeutics Product Picture and Specifications of Bristol-Myers Squibb Table Blood Cancer Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bristol-Myers Squibb Blood Cancer Therapeutics Market Share (2018-2020) Table Bristol-Myers Squibb Main Business Table Bristol-Myers Squibb Recent Development Table GlaxoSmithKline Company Profile Figure Blood Cancer Therapeutics Product Picture and Specifications of GlaxoSmithKline Table Blood Cancer Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure GlaxoSmithKline Blood Cancer Therapeutics Market Share (2018-2020) Table GlaxoSmithKline Main Business Table GlaxoSmithKline Recent Development Table Roche Company Profile Figure Blood Cancer Therapeutics Product Picture and Specifications of Roche Table Blood Cancer Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Roche Blood Cancer Therapeutics Market Share (2018-2020) Table Roche Main Business Table Roche Recent Development Table Novartis Company Profile Figure Blood Cancer Therapeutics Product Picture and Specifications of Novartis Table Blood Cancer Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Novartis Blood Cancer Therapeutics Market Share (2018-2020) Table Novartis Main Business Table Novartis Recent Development Table Boehringer Ingelheim Company Profile Figure Blood Cancer Therapeutics Product Picture and Specifications of Boehringer Ingelheim Table Blood Cancer Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Boehringer Ingelheim Blood Cancer Therapeutics Market Share (2018-2020) Table Boehringer Ingelheim Main Business Table Boehringer Ingelheim Recent Development Table Pfizer Company Profile Figure Blood Cancer Therapeutics Product Picture and Specifications of Pfizer Table Blood Cancer Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Pfizer Blood Cancer Therapeutics Market Share (2018-2020) Table Pfizer Main Business Table Pfizer Recent Development Table Sanofi Company Profile Figure Blood Cancer Therapeutics Product Picture and Specifications of Sanofi Table Blood Cancer Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Sanofi Blood Cancer Therapeutics Market Share (2018-2020) Table Sanofi Main Business Table Sanofi Recent Development Table Global Blood Cancer Therapeutics Sales (K Units) by Region (2015-2020) Table Global Blood Cancer Therapeutics Sales Market Share by Region (2015-2019) Figure Global Blood Cancer Therapeutics Sales Market Share by Region (2015-2019) Figure Global Blood Cancer Therapeutics Sales Market Share by Region in 2018 Table Global Blood Cancer Therapeutics Revenue (Million US$) by Region (2015-2020) Table Global Blood Cancer Therapeutics Revenue Market Share by Region (2015-2020) Figure Global Blood Cancer Therapeutics Revenue Market Share by Region (2015-2020) Figure Global Blood Cancer Therapeutics Revenue Market Share by Region in 2019 Table Global Blood Cancer Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Blood Cancer Therapeutics Sales (K Units) Growth Rate (2015-2020) Figure Europe Blood Cancer Therapeutics Sales (K Units) Growth Rate (2015-2020) Table Europe Blood Cancer Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Blood Cancer Therapeutics Sales (K Units) Growth Rate (2015-2020) Table Japan Blood Cancer Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Blood Cancer Therapeutics Sales (K Units) Growth Rate (2015-2020) Table China Blood Cancer Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Blood Cancer Therapeutics Sales by Type (2015-2020) Table Global Blood Cancer Therapeutics Sales Market Share by Type (2015-2020) Figure Global Blood Cancer Therapeutics Sales Market Share by Type in 2019 Table Global Blood Cancer Therapeutics Revenue by Type (2015-2020) Table Global Blood Cancer Therapeutics Revenue Market Share by Type (2015-2020) Figure Global Blood Cancer Therapeutics Revenue Market Share by Type in 2019 Figure Global Chronic Myeloid Leukemia (CML) Sales Growth Rate (2015-2025) Figure Global Chronic Myeloid Leukemia (CML) Price (2015-2020) Figure Global Acute Lymphocytic Leukemia (ALL) Sales Growth Rate (2015-2025) Figure Global Acute Lymphocytic Leukemia (ALL) Price (2015-2020) Figure Global Chronic Lymphocytic Leukemia (CLL) Sales Growth Rate (2015-2025) Figure Global Chronic Lymphocytic Leukemia (CLL) Price (2015-2020) Figure Global Acute Myeloid Leukemia (AML) Sales Growth Rate (2015-2025) Figure Global Acute Myeloid Leukemia (AML) Price (2015-2020) Table Global Blood Cancer Therapeutics Sales Market Share by Application (2015-2020) Figure Global Blood Cancer Therapeutics Sales Market Share by Application in 2019 Figure Global Cancer Research Centers Sales Growth Rate (2015-2025) Figure Global Cancer Hospital Sales Growth Rate (2015-2025) Figure Global Surgical Centers Sales Growth Rate (2015-2025) Figure Global Clinics Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Blood Cancer Therapeutics Table Key Players of Downstream Markets Figure Sales Channel Figure Global Blood Cancer Therapeutics Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Blood Cancer Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Blood Cancer Therapeutics Price and Trend Forecast (2020-2025) Table Global Blood Cancer Therapeutics Sales (K Units) Forecast by Region (2020-2025) Figure Global Blood Cancer Therapeutics Production Market Share Forecast by Region (2020-2025) Figure North America Blood Cancer Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Blood Cancer Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Blood Cancer Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Blood Cancer Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Blood Cancer Therapeutics Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Blood Cancer Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Blood Cancer Therapeutics Production (K Units) Growth Rate Forecast (2020-2025) Figure China Blood Cancer Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

AbbVie AstraZeneca Bristol-Myers Squibb GlaxoSmithKline Roche Novartis Boehringer Ingelheim